---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-26-002928"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:20:27.080041+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience to voluntarily deregister, cease SEC reporting; CFO and director resign

## Summary
- CFO William Sullivan resigns effective March 30, 2026; board member Alison Cornell resigns immediately as part of cost-cutting measures.
- Company expects to file Form 15 on March 30, 2026 to suspend SEC reporting obligations and delist from OTC markets.
- CEO letter states anticipated revenue from AgTech distribution partner in coming months, targeting first-time positive cash flow.
- Board compensation eliminated; CEO continues to invest personal capital; alignment with shareholders emphasized.
- University of Georgia granted funds to study Zivo's product for Avian Influenza using company's algal immune-modulating technology.

## SEC filing metadata
- accession: 0001654954-26-002928
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495426002928/0001654954-26-002928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495426002928/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-26-002928
- JSON: https://secwatch.observer/filing/0001654954-26-002928.json
- Plain text: https://secwatch.observer/filing/0001654954-26-002928.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.